Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€12.20
10.08.21
-
10.08.22
-13.93%
13.08.21

Probably not worthwhile Investment
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€16.00
12.03.21
€22.00
12.03.22
-62.19%
12.08.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
MaxCyte Inc

Start price
Target price
Perf. (%)
€10.00
06.02.21
€10.00
06.02.22
33.00%
12.08.21

Capable Management
Future proof or reliable business model
Higher risks for its business
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€2.30
17.06.20
€5.00
04.11.21
73.91%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€8.40
09.08.21
€13.00
09.08.22
42.86%
10.08.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
buy
Dynatronics Corp

Start price
Target price
Perf. (%)
€1.07
26.07.21
€2.50
26.07.22
-1.87%
07.08.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Roche Holding AG

Start price
Target price
Perf. (%)
€246.00
08.07.21
-
08.07.22
-
06.08.21

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.45
23.09.20
-
04.11.21
-47.51%
15.07.21

Probably not worthwhile Investment
iBio Inc.

Start price
Target price
Perf. (%)
€36.75
22.08.20
-
04.11.21
-25.14%
15.07.21

Risky Investment
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€4.53
02.07.21
-
02.07.22
18.90%
13.07.21

Risky Investment
buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€13.06
30.06.21
€16.00
30.06.22
-39.28%
09.07.21

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€7.20
25.06.21
-
25.06.22
-26.39%
30.06.21

Could be very worthwhile Investment >20% year
CytRx Corp.

Start price
Target price
Perf. (%)
€2.50
13.06.21
-
13.06.22
-66.00%
27.06.21

Risky Investment
GNI Group Ltd

Start price
Target price
Perf. (%)
€24.00
18.10.20
€12.00
04.11.21
-35.42%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.78
12.12.20
€2.00
12.12.21
4.76%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
vTv Therapeutics Inc

Start price
Target price
Perf. (%)
€2.30
12.12.20
€1.00
12.12.21
-14.22%
26.06.21

Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
overvalued
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€2.41
31.03.19
€2.71
04.11.21
-31.57%
22.06.21

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€19.02
19.05.21
-
19.05.22
25.45%
22.06.21

Risky Investment
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.30
02.06.21
-
02.06.22
9.09%
20.06.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€6.50
22.08.20
-
04.11.21
36.15%
17.06.21

Probably not worthwhile Investment
iBio Inc.

Start price
Target price
Perf. (%)
€33.50
06.05.21
€25.00
06.05.22
-8.77%
28.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
iBio Inc.

Start price
Target price
Perf. (%)
€41.75
20.02.21
€27.50
20.02.22
-19.76%
06.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Precipio Inc

Start price
Target price
Perf. (%)
€2.03
03.05.21
€3.00
03.05.22
194.54%
04.05.21

Could be very worthwhile Investment >20% year
Good culture
Capable Management
Few uniques
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.74
19.04.21
€3.00
19.04.22
7.47%
03.05.21

Could be worthwhile Investment >10% per year